Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids

Exclusion Criteria

• •The subject is pregnant or breast-feeding or is planning a pregnancy within the duration of the treatment period of the study.
• •History of uterus surgery that would interfere with the study.
• •The subject's condition is so severe that she will require surgery within 6 months regardless of the treatment provided.
• •Undiagnosed abnormal uterine bleeding.
• •Significant risk of osteoporosis or history of, or known osteoporosis or other metabolic bone disease.